2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: 2-Methoxyestradiol may stop the growth of cancer by stopping blood flow to the
tumor.
PURPOSE: Phase I trial to study the effectiveness of 2-methoxyestradiol in treating patients
who have advanced solid tumors.